rs4814597

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002594.5(PCSK2):​c.177+3506A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 152,110 control chromosomes in the GnomAD database, including 15,861 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15861 hom., cov: 33)

Consequence

PCSK2
NM_002594.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.838

Publications

3 publications found
Variant links:
Genes affected
PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002594.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK2
NM_002594.5
MANE Select
c.177+3506A>G
intron
N/ANP_002585.2
PCSK2
NM_001201528.2
c.120+3506A>G
intron
N/ANP_001188457.1
PCSK2
NM_001201529.3
c.177+3506A>G
intron
N/ANP_001188458.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK2
ENST00000262545.7
TSL:1 MANE Select
c.177+3506A>G
intron
N/AENSP00000262545.2
PCSK2
ENST00000377899.5
TSL:1
c.120+3506A>G
intron
N/AENSP00000367131.1
PCSK2
ENST00000536609.1
TSL:2
c.177+3506A>G
intron
N/AENSP00000437458.1

Frequencies

GnomAD3 genomes
AF:
0.443
AC:
67404
AN:
151990
Hom.:
15843
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.290
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.425
Gnomad EAS
AF:
0.160
Gnomad SAS
AF:
0.287
Gnomad FIN
AF:
0.414
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.396
Gnomad OTH
AF:
0.441
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.443
AC:
67458
AN:
152110
Hom.:
15861
Cov.:
33
AF XY:
0.441
AC XY:
32787
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.603
AC:
25011
AN:
41494
American (AMR)
AF:
0.404
AC:
6169
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.425
AC:
1476
AN:
3470
East Asian (EAS)
AF:
0.160
AC:
832
AN:
5186
South Asian (SAS)
AF:
0.287
AC:
1384
AN:
4826
European-Finnish (FIN)
AF:
0.414
AC:
4373
AN:
10570
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.396
AC:
26885
AN:
67964
Other (OTH)
AF:
0.436
AC:
919
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1903
3806
5709
7612
9515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.421
Hom.:
1772
Bravo
AF:
0.453
Asia WGS
AF:
0.269
AC:
935
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.39
DANN
Benign
0.53
PhyloP100
-0.84
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4814597; hg19: chr20-17211633; API